• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰弱对慢性阻塞性肺疾病主要不良心血管事件的影响

Impact of Frailty on Major Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease.

作者信息

Hamada Kazuki, Oishi Keiji, Yamamoto Tasuku, Murata Yoriyuki, Asami-Noyama Maki, Edakuni Nobutaka, Hirano Tsunahiko, Abe Takeshi, Nakatsui Masahiko, Asai Yoshiyuki, Matsunaga Kazuto

机构信息

Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.

AI Systems Medicine Research and Training Center, Graduate School of Medicine, Yamaguchi University and Yamaguchi University Hospital, Ube, Yamaguchi, Japan.

出版信息

Int J Chron Obstruct Pulmon Dis. 2025 Sep 4;20:3111-3122. doi: 10.2147/COPD.S538054. eCollection 2025.

DOI:10.2147/COPD.S538054
PMID:40932900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12417696/
Abstract

PURPOSE

Chronic obstructive pulmonary disease (COPD) is associated with frailty and leads to poor outcomes. The relationship between COPD and cardiovascular events is well established. However, the impact of frailty on cardiovascular events in COPD patients remains unknown. We aimed to evaluate the long-term association between frailty, assessed using the hospital frailty risk score (HFRS), and major adverse cardiovascular events (MACE) in COPD patients.

PATIENTS AND METHODS

We recruited Japanese patients with COPD between 2013 and 2023 from Sado-Himawari Net, a regional electronic health record system in Sado City, Niigata Prefecture, Japan. MACE were defined as a composite of acute coronary syndrome, heart failure, and stroke. We classified the participants into four frailty categories according to HFRS: no-frailty with HFRS=0, low with HFRS >0 and <5, intermediate with HFRS ≥5 and <15, and high with HFRS ≥15. We used a Cox regression model adjusted for age, sex, inhaled treatments, and comorbidities to evaluate the hazard ratio (HR) for MACE.

RESULTS

We recruited 1527 patients with COPD. In multivariable analysis, COPD was associated with MACE as follows: no-frailty versus low HFRS (HR, 1.47 [95% confidence interval, 1.01-2.14], p<0.05), intermediate HFRS (HR 2.00 [1.34-2.97], p<0.001), and high HFRS (HR 2.62 [1.50-4.59], p<0.001). Similar relationships were observed even after adjusting for the severity of airflow limitation and COPD exacerbation.

CONCLUSION

Frailty was independently associated with MACE in COPD patients during the 10-year follow-up period. Frailty assessment supports the identification of patients with COPD at risk of MACE.

摘要

目的

慢性阻塞性肺疾病(COPD)与身体虚弱相关,并导致不良后果。COPD与心血管事件之间的关系已得到充分证实。然而,身体虚弱对COPD患者心血管事件的影响尚不清楚。我们旨在评估使用医院虚弱风险评分(HFRS)评估的身体虚弱与COPD患者主要不良心血管事件(MACE)之间的长期关联。

患者和方法

我们从日本新潟县佐渡市的区域电子健康记录系统佐渡向日葵网络中招募了2013年至2023年期间的日本COPD患者。MACE被定义为急性冠状动脉综合征、心力衰竭和中风的综合。我们根据HFRS将参与者分为四类虚弱:HFRS=0为无虚弱,HFRS>0且<5为低虚弱,HFRS≥5且<15为中度虚弱,HFRS≥15为高虚弱。我们使用调整了年龄、性别、吸入治疗和合并症的Cox回归模型来评估MACE的风险比(HR)。

结果

我们招募了1527例COPD患者。在多变量分析中,COPD与MACE的关联如下:无虚弱与低HFRS(HR,1.47[95%置信区间,1.01-2.14],p<0.05)、中度HFRS(HR 2.00[1.34-2.97],p<0.001)和高HFRS(HR 2.62[1.50-4.59],p<0.001)。即使在调整气流受限严重程度和COPD急性加重后,也观察到了类似的关系。

结论

在10年随访期间,身体虚弱与COPD患者的MACE独立相关。虚弱评估有助于识别有MACE风险的COPD患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fb1/12417696/0e1eb679f770/COPD-20-3111-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fb1/12417696/9d48b1705ba9/COPD-20-3111-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fb1/12417696/24561d3c8174/COPD-20-3111-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fb1/12417696/0e1eb679f770/COPD-20-3111-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fb1/12417696/9d48b1705ba9/COPD-20-3111-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fb1/12417696/24561d3c8174/COPD-20-3111-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fb1/12417696/0e1eb679f770/COPD-20-3111-g0003.jpg

相似文献

1
Impact of Frailty on Major Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease.衰弱对慢性阻塞性肺疾病主要不良心血管事件的影响
Int J Chron Obstruct Pulmon Dis. 2025 Sep 4;20:3111-3122. doi: 10.2147/COPD.S538054. eCollection 2025.
2
Association of Patient-Reported Outcome Patterns and Major Clinical Factors with Frailty in Stable COPD.稳定期慢性阻塞性肺疾病患者报告结局模式及主要临床因素与衰弱的关联
Int J Chron Obstruct Pulmon Dis. 2025 Jun 12;20:1927-1937. doi: 10.2147/COPD.S517270. eCollection 2025.
3
Frailty and Exacerbation of Chronic Obstructive Pulmonary Disease: Is There Any Association?衰弱与慢性阻塞性肺疾病恶化:二者有关联吗?
Int J Chron Obstruct Pulmon Dis. 2024 May 24;19:1131-1139. doi: 10.2147/COPD.S455316. eCollection 2024.
4
Frailty Is Associated With Increased 30-day Readmissions and Costs After Total Shoulder Arthroplasty.虚弱与全肩关节置换术后30天再入院率及费用增加相关。
Clin Orthop Relat Res. 2025 Apr 10. doi: 10.1097/CORR.0000000000003461.
5
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
6
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
7
Clinical frailty predicts long-term survival and return to functional status following fenestrated and branched aortic repair for thoracoabdominal aortic aneurysm.临床衰弱可预测胸腹主动脉瘤开窗及分支主动脉修复术后的长期生存及功能状态恢复情况。
J Vasc Surg. 2025 Jul;82(1):62-71. doi: 10.1016/j.jvs.2025.03.058. Epub 2025 Mar 12.
8
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
9
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病(COPD)药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
10
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.

本文引用的文献

1
Increased Risk of Severe Cardiovascular Events Following Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the EXACOS-CV Study in Japan.慢性阻塞性肺疾病加重后发生严重心血管事件的风险增加:日本 EXACOS-CV 研究结果。
Adv Ther. 2024 Aug;41(8):3362-3377. doi: 10.1007/s12325-024-02920-y. Epub 2024 Jul 8.
2
Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.慢性阻塞性肺疾病加重增加后续心血管事件风险:COPDGene 研究的纵向分析。
J Am Heart Assoc. 2024 Jun 4;13(11):e033882. doi: 10.1161/JAHA.123.033882. Epub 2024 May 31.
3
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.
慢性阻塞性肺疾病急性加重后长期心血管风险增加。
Heart. 2024 Apr 25;110(10):702-709. doi: 10.1136/heartjnl-2023-323487.
4
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.慢性阻塞性肺疾病急性加重后非致命性心血管事件的时间风险:一项基于人群的研究。
Am J Respir Crit Care Med. 2024 Apr 15;209(8):960-972. doi: 10.1164/rccm.202307-1122OC.
5
COPD and multimorbidity: recognising and addressing a syndemic occurrence.COPD 与多种共病:识别和应对综合征发生。
Lancet Respir Med. 2023 Nov;11(11):1020-1034. doi: 10.1016/S2213-2600(23)00261-8. Epub 2023 Sep 8.
6
Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study.肺功能保存率受损、肺功能测定异常及慢性阻塞性肺疾病加速衰弱进展:一项前瞻性队列研究的证据
Chest. 2024 Mar;165(3):573-582. doi: 10.1016/j.chest.2023.07.020. Epub 2023 Jul 26.
7
Prevalence and clinical impact of frailty in COPD: a systematic review and meta-analysis.COPD 患者衰弱的患病率和临床影响:系统评价和荟萃分析。
BMC Pulm Med. 2023 May 12;23(1):164. doi: 10.1186/s12890-023-02454-z.
8
Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality.多种器官系统的异质性衰老与慢性疾病和死亡率的预测。
Nat Med. 2023 May;29(5):1221-1231. doi: 10.1038/s41591-023-02296-6. Epub 2023 Apr 6.
9
Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study.肺功能障碍和 COPD 增加心血管疾病风险:加拿大队列研究。
Chest. 2023 Sep;164(3):637-649. doi: 10.1016/j.chest.2023.02.045. Epub 2023 Mar 4.
10
Validity of Diagnostic Algorithms for Cardiovascular Diseases in Japanese Health Insurance Claims.日本健康保险理赔中心血管疾病诊断算法的有效性
Circ J. 2023 Mar 24;87(4):536-542. doi: 10.1253/circj.CJ-22-0566. Epub 2023 Jan 28.